US 7553971
Aryl aniline β2 adrenergic receptor agonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7553971 (Aryl aniline β2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P15/06